Detection of hepatitis C virus core antigen in blood donors using a new enzyme immunoassay

Journal of Family and Community Medicine

Volumn 11, Issue 3, 2004, Pages 103-107

  Alzahrani, Alhusain ^a   Obeid, Obeid ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Blood Donors; Core Antigen; ELISA.; Hepatitis C virus

Indexed keywords

EID: 84867296809     PISSN: 22308229     EISSN: 2229340X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fathalla SE, Al-Jama AA. Prevalence of hepatitis C viral antibodies in blood donors, pregnant women and hemodialysis patients in the Eastern Province of Saudi Arabia: A preliminary study. Saudi Med J 1993; 14:265.
2. Bernvil SS, Andrews VJ, Kariem AA. Hepatitis C antibody prevalence in Saudi Arabian blood donor population. Ann Saudi Med 1991;11:563-7.
3. Bernvil SS, Andrews VJ, Sasich F. Second-generation anti-HCV screening in a Saudi Arabian donor population. Vox Sang 1994; 66: 33-6.
4. Abdelaal M, Rowbottom D, Zawawi T. Epidemiology of hepatitis C virus: A study of male blood donors in Saudi Arabia. Transfusion 1994; 34:135-7.
5. Mehdi SR, Pophali A, Al-Abdul Rahim KA. Prevalence of hepatitis B and C and blood donors. Saudi Med J 2000; 21(10):942-4.
6. Shobokshi OA. Keynote address. Overview of viral hepatitis A through to TT virus. The Sixth Saudi Gastroenterology Association meeting, Jeddah, Saudi Arabia. 30 November-2 December 1999.
7. Courouce AM, Le Marrec N, Bouchardeau F, Razer A, Maniez M, et al. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 2000;40(10):1198-202.
8. Nagai T, Nagai T, Okazaki T. Relationship between cryoglobulins and hepatitis C virus (HCV) core antigen or antibody titers. Clin Chem Lab Med 2004;42(1):105-6.
9. Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol 2003;41(7):3212-20.
10. Icardi G, Bruzzone B, Gota F, Torre F, Giannini E, Massone L, et al. A new assay for hepatitis C virus (HCV) core antigen detection: An alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? Ann Ig 2003;15(6):863-70.
11. Bouvier-Alias M, Patel K, Dahari H, Beaucourt S, Larderie P, Blatt L, et al. Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication. Hepatology 2002;36(1):211-8.
12. Komatsu F, Takasaki K. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients. Liver 1999; 19(5):375-80.
13. Maynard M, Pradat P, Berthillon P, Picchio G, Voirin N, Martinot M, et al. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients′ response to therapy. J Viral Hepat 2003; 10(4):318-23.
14. Nakamuta M, Shimohashi N, Tada S, Kinukawa N, Enjoji M, Uchimura K, et al. Serum levels of HCV RNA and core protein before and after incubation at 37 degrees C for 24 h. Hepatol Res 2001; 19(3):254-62.
15. Netski DM, Wang XH, Mehta SH, Nelson K, Celentano D, Thongsawat S, Maneekarn N, et al. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in the injection drug users. J Clin Microbiol 2004;42(4):1631-6.
16. Dwyer R. The ADVIA Centaur((R)) infectious disease assays: A technical review. J Clin Virol 2004; 30 Suppl 1:S1-4.
17. Raker CA, Tabor E, Okayama A, Yu MY, Kohara M, Mueller NE, et al. HCV core antigen as an alternative to NAT to detect HCV viremia. Transfusion 2004; 44(2):307-8